JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
WM Holding Company, LLC, a Leading Technology Platform to the Cannabis Industry, Completes Business Combination With Silver Spike Acquisition Corp.
-
WalkMe (WKME) IPO Prices at $31
-
Protagonist Therapeutics (PTGX) Announces Pricing of $115 Million Upsized Public Offering of Common Stock
-
WalkMe Announces Pricing of Initial Public Offering
-
Protagonist Therapeutics Announces Pricing of $115 Million Upsized Public Offering of Common Stock
-
Clearside Biomedical (CLSD) PT Raised to $9 at JMP Securities, Following Clinical Business Update
-
Sutro Biopharma to Participate in Two Virtual Investor Conferences in June
-
Arbor Realty Trust Announces Pricing of Public Offering of Common Stock
-
1stdibs.com, Inc. Announces Closing of Initial Public Offering
-
1stdibs.com, Inc. Announces Closing of Initial Public Offering
-
Protagonist Therapeutics (PTGX) Announces Proposed $100M Public Offering of Common Stock
-
Protagonist Therapeutics Announces Proposed Public Offering of Common Stock
-
Arbor Realty Trust (ABR) Announces 6M Share Public Offering of Common Stock
-
Arbor Realty Trust Announces Public Offering of Common Stock
-
Tremor International Ltd. Launches Initial Public Offering on Nasdaq
-
Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference
-
ReCode Therapeutics to Participate in Upcoming June Investor Conferences
-
eFFECTOR Therapeutics to Present at JMP Securities 2021 Life Sciences Conference
-
Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference
-
TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference
-
TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference
-
UPDATE: JMP Securities Starts Squarespace (SQSP) at Market Outperform
-
Protagonist Therapeutics (PTGX) PT Raised to $55 at JMP Securities, Following Clinical Business Update
-
Marinus Pharmaceuticals to Present at Multiple Upcoming Investor Conferences
-
Orthofix Announces Participation in Upcoming JMP Securities Life Sciences Conference
-
Larimar Therapeutics to Present at the JMP Securities Life Sciences Conference
-
JMP Group Divests Interest in Harvest Capital Credit Corporation
-
NextCure to Present at the JMP Securities Life Sciences Conference
-
NextCure to Present at the JMP Securities Life Sciences Conference
-
Precigen to Present at the JMP Securities Life Sciences Conference
-
Prothena to Participate in JMP Securities Life Sciences Conference on June 16
-
Prothena to Participate in JMP Securities Life Sciences Conference on June 16
-
1stdibs.com (DIBS) IPO Opens 8% Higher
-
Minerva Neurosciences to Present at JMP Securities Life Sciences Conference
-
Minerva Neurosciences to Present at JMP Securities Life Sciences Conference
-
Catalyst Biosciences to Participate in Two Upcoming Investor Conferences
-
Viridian Therapeutics to Participate in the JMP Securities Life Sciences Conference
-
Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference
-
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in June
-
Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference
-
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in June
-
Kura Oncology to Participate in JMP Securities Life Sciences Conference
-
AVROBIO to Present at the JMP Securities Life Sciences Conference
-
Baudax Bio to Participate in the JMP Securities Life Sciences Conference
-
ProQR to Present at Upcoming JMP Securities Life Sciences Conference
-
ProQR to Present at Upcoming JMP Securities Life Sciences Conference
-
Enanta Pharmaceuticals to Participate in Two Investor Conferences in June
-
Baudax Bio to Participate in the JMP Securities Life Sciences Conference
-
Seres Therapeutics to Present at JMP Securities Life Sciences Conference
-
UPDATE: JMP Securities Upgrades Iovanace Biotherapeutics (IOVA) to Market Outperform; Data at ASCO 'Looks Impressive'

